Pricing Log in Create free account

Milestone Pharmaceuticals Inc. (MIST) vs Rallybio Corporation (RLYB)

Milestone Pharmaceuticals Inc. and Rallybio Corporation are both Biotechnology companies. Milestone Pharmaceuticals Inc. and Rallybio Corporation are of similar size ($86.2M and $84.5M). Milestone Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 3.3×. Rallybio Corporation has the higher net margin (0.00% vs −1,586.0%) and the lower return on invested capital (−944.4% vs 0.00%). Across the 17 metrics below, Rallybio Corporation leads on 13 and Milestone Pharmaceuticals Inc. on 4.

Valuation

Metric MIST RLYB Biotechnology median
P/E n/m 3.35 10.60
P/S 19.90 104.91 9.40
P/B 5.79 0.98 2.13
Price to free cash flow n/m 2.91 25.18
EV/EBITDA 0.08 0.03 0.66
EV/Sales (1.13) (0.79) 9.02
Earnings yield (90.79%) 29.85% (32.88%)
Free cash flow yield (58.48%) 34.39% (23.13%)

Profitability

Metric MIST RLYB Biotechnology median
Gross margin 13.27% 100.00% 68.51%
Operating margin (1,479.69%) 0.00% 0.00%
Net margin (1,586.01%) 0.00% 0.00%
Free cash flow margin (1,163.79%) 0.00% 0.00%
Return on equity (35,522.62%) 34.52% (51.96%)
Return on assets (73.36%) 32.85% (46.06%)
Return on invested capital 0.00% (944.36%) 0.00%

Growth

Metric MIST RLYB Biotechnology median
Revenue growth (TTM) — 1.18% 6.76%
EPS growth (last fiscal year) (11.94%) 85.06% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MIST RLYB Biotechnology median
Debt to equity 3.25 0.00 0.00
Current ratio 8.13 28.87 4.97
Net debt to EBITDA 0.79 1.63 1.01

Dividend

Metric MIST RLYB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MIST RLYB Biotechnology median
Market cap 86.21m 84.47m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack